Are you a healthy female aged between 25 to 50 years? Join a patch clinical trial and help patients with multiple sclerosis.

Scientia Clinical trial is seeking participants to join a clinical trial. The clinical trial involves wearing a patch for one week. Participants will need to be available for 10 days …

CONDITION: Other

GENDER: Females

AGE GROUP: 25 to 50 years

TRIAL STATUS: Completed

Healthy Caucasian Males Needed for a Clinical Trial!

We are testing a treatment developed for polycythemia vera, which is a condition that has limited therapeutic options and no cure is currently available. The medication will be administered subcutaneously …

CONDITION: Other

GENDER: Males

AGE GROUP: 18 to 50 years

TRIAL STATUS: Completed

Do you have idiopathic pulmonary fibrosis?

Australian researchers are testing a new medication for idiopathic pulmonary fibrosis. This is a 60 day study with 10 separate visits. You will be treated at no cost, and most …

CONDITION: Respiratory

GENDER: Both males and females

AGE GROUP: 40 to 80 years

TRIAL STATUS: Completed

The FOOTSTEP Study

Footwear for self-managing knee osteoarthritis symptoms– volunteers needed! Researchers from the Centre for Health, Exercise and Sports Medicine at The University of Melbourne are conducting a research study to compare two …

CONDITION: Musculoskeletal

GENDER: Both males and females

AGE GROUP: 50 and above

TRIAL STATUS: Completed

The TARGET Study

This project will specifically compare the effects of two different exercise programs for individuals with knee osteoarthritis who have higher body weights and evaluate if they respond differently to either …

CONDITION: Musculoskeletal

GENDER: Both males and females

AGE GROUP: 50 and above

TRIAL STATUS: Completed

NOX66 and Palliative Radiotherapy in Patients with Late-Stage Prostate Cancer

The use of NOX66 as a tumour cell-specific sensitiser of radiation therapy may provide greater response to targeted radiation therapy within the tumour cells, with the tumour specific nature of …

CONDITION: Cancer

GENDER: Males

AGE GROUP: 18 and above

TRIAL STATUS: Completed

Kava in the treatment of Generalised Anxiety Disorder (KGAD)

An NHMRC funded clinical trial investigating the effects of a herbal medicine extract called Kava for individuals with Generalised Anxiety Disorder (GAD). The KGAD study is an 18-week, double blind, …

CONDITION: Mental Health

GENDER: Both males and females

AGE GROUP: 18 to 70 years

TRIAL STATUS: Completed

N-acetylcysteine (NAC) in the treatment of Obsessive-Compulsive Disorder (OCD)

A 24-week, double blind placebo study investigating the effects of the amino acid ‘N-acetylcysteine’ (NAC) in Obsessive-Compulsive Disorder (OCD). This study will determine if NAC is an effective treatment for …

CONDITION: Mental Health

GENDER: Both males and females

AGE GROUP: 18 to 75 years

TRIAL STATUS: Completed

Dynavax Melanoma Trial

This trial is designed to evaluate the safety, tolerability, and preliminary efficacy of intra-tumour injections of SD-101 in combination with intravenous Keytruda (pembrolizumab) in patients with metastatic melanoma. Patients can have progressed …

CONDITION: Cancer

GENDER: Both males and females

AGE GROUP: 18 to 70 years

TRIAL STATUS: Completed

Facial Acne Medication Study

Adults and Children ages 9+ may qualify for a study of an investigational facial acne medication. To participate you must: Have at least 20 red irritated pimples and at least …

CONDITION: Skin

GENDER: Both males and females

AGE GROUP: 9 and above

TRIAL STATUS: Completed

Do you have Asthma?

Australian researchers are trialing a potential new treatment for Asthma. They are looking for volunteers to take part in the Australian arm of a worldwide study. This study will be …

CONDITION: Respiratory

GENDER: Both males and females

AGE GROUP: 18 to 100 years

TRIAL STATUS: Completed

Weekend Study

20150164: This study is investigating a drug that has been developed for the treatment of a disease called Paroxysmal nocturnal hemoglobinuria (PNH) – PNH is a disease where red blood …

CONDITION: Other

GENDER: Males

AGE GROUP: 18 to 45 years

TRIAL STATUS: Completed

Atopic Dermatitis

This research project is testing the safety, tolerability and efficacy (the effect of the drug on the body) of AKP-11 administered to participants with atopic dermatitis. You are invited to …

CONDITION: Skin

GENDER: Both males and females

AGE GROUP: 18 and above

TRIAL STATUS: Completed

Mild To Moderate Plaque Psoriasis

AKP-11 is being developed as a treatment for psoriasis. AKP-11 has been tested on a small population of psoriasis subjects previously, which showed a reduction in psoriasis severity. By participating …

CONDITION: Skin

GENDER: Both males and females

AGE GROUP: 18 and above

TRIAL STATUS: Completed

COPD – FLASH STUDY – Multi-centre

Are you aged 40 years or over? Do you suffer from COPD? Are you a current or previous smoker? Using Seretide? If you answered yes to these questions, you may be …

CONDITION: Respiratory

GENDER: Both males and females

AGE GROUP: 40 and above

TRIAL STATUS: Completed

ACUTE PAIN – Survey Assessment

people suffering with Acute Pain 1 visit of approximately 2 hours assessing a survey for people affected by Acute Pain in Australia If you suffer from Acute Pain or know someone who does, contact us for …

CONDITION: Other

GENDER: Both males and females

AGE GROUP: 18 and above

TRIAL STATUS: Completed

CHRONIC PAIN – Survey Assessment

people suffering with Chronic Pain 1 visit of approximately 2 hours assessing a survey for people affected by Chronic Pain in Australia If you suffer from Chronic Pain or know someone who does, …

CONDITION: Other

GENDER: Both males and females

AGE GROUP: 18 and above

TRIAL STATUS: Completed

An Open-label, Long-term, Safety and Efficacy Study of Intranasal Esketamine in Treatment-resistant Depression

This is a Phase 3, multi centre, open label, long term (up to 52 weeks) study of the safety and efficacy of esketamine administered by nasal spray in treatment resistant depression. Study participants will …

CONDITION: Mental Health

GENDER: Both males and females

AGE GROUP: 18 and above

TRIAL STATUS: Completed